|
Introduction
This workshop provides both the theoretical and
practical skills in developing, implementing and
evaluating a smoking cessation program in the
workplace, clinic or hospital setting. Specific smoking
trends of the Middle East region will also be addressed
so that the workshop is locally and culturally relevant.
Target Audience
- Health and wellness professionals
- Healthcare professionals & Health Promotion
Specialists
- Clinicians
- S&HE Professionals that are charged with
implementing a smoking cessation program and
policy within their company
Workshop Objectives
- To understand the three facets of tobacco
dependence and Health Benefits of Quitting
- To understand the current uses and dangers of
Shisha
- To learn and apply the methodologies and tools of
Carbon Monoxide Monitoring
- To understand and apply The 5A’s for Brief
Intervention
- To develop step by step procedures and materials
for conducting individual and group smoking
cessation counseling—from intake interview
through long-term follow-up
- To gain an understanding of the Pharmacotherapy
associated with smoking cessation programs
Learn how to treat smokers with co-morbid
psychiatric disorders and poly-substance abuse
- To gain an understanding of the social support
required with smoking cessation programs
- Learn how strategies for relapse prevention
- Step by step details of how to set up a Worksite,
Clinic or Hospital Based Program
- To gain an understanding on how to develop
telephone counseling and quit-lines programs.
Workshop Description
With a high incidence of smoking in the region all
SH&E Professionals, healthcare, and health promotion
professionals will be made aware of how smoking
affects the population health and safety at work. This
workshop provides both the science and practice
so that professionals can implement a successful
program based on the current global standards in
smoking cessation benchmarks and practices.
Workshop Instructor – Dr. Mitchell Nides
Dr. Nides has been in the tobacco cessation field for over 20
years. Over that time his research and clinical practice has
demonstrated that tobacco users can have the greatest success
in quitting when cognitive-behavioral treatments are combined
with approved medications and social support. He has been the
principal investigator for over 50 clinical trials of smoking cessation
medications from Nicotine Replacement Therapy to Zyban and
Champix. His educational background is in Psychology, and has
developed a number of strategies to teach tobacco users how to
deal with the emotional and behavioral aspects of quitting. For
the past five years he has designed and directed an intensive and
comprehensive year-long smoking cessation program for workers in
the Entertainment Industry in Los Angeles.
>>> Other Courses <<<
|